A Cost-Effectiveness Analysis of Diffuse Large B-Cell Lymphoma Treatment Pathways in the United States by Anik R. Patel, Bradley Kievit, Ken Hasegawa, Markqayne Ray, Rishika Sharma, Sarahmaria Hofmann, Rob Blissett, Frederick L. Locke

Get full text

Tumor gene expression signatures associated with outcome in large B−cell lymphoma treated with CD19-directed CAR T−cell therapy (axicabtagene ciloleucel) by Yuan Tian, Justin Budka, Frederick L. Locke, Jason R. Westin, Christina To, Gayatri Tiwari, Daqin Mao, Davide Bedognetti, Rhine R. Shen, Jorge Andrade, Simone Filosto

Get full text

4-1BB and optimized CD28 co-stimulation enhances function of human mono-specific and bi-specific third-generation CAR T cells by Frederick L Locke, Yannick Bulliard, Bin Yu, Marco L Davila, Emiliano Roselli, Justin C Boucher, Gongbo Li, Hiroshi Kotani, Kristen Spitler, Kayla Reid, Estelle V Cervantes, Nhan Tu, Sae Bom Lee

Get full text

Radiomic features of PET/CT imaging of large B cell lymphoma lesions predicts CAR T cell therapy efficacy by Yoganand Balagurunathan, Zhouping Wei, Jin Qi, Zachary Thompson, Erin Dean, Erin Dean, Hong Lu, Hong Lu, Saran Vardhanabhuti, Salvatore Corallo, Jung W. Choi, Jenny J. Kim, Mike Mattie, Michael Jain, Frederick L. Locke

Get full text

Real-world outcomes with tisagenlecleucel in aggressive B-cell lymphoma: subgroup analyses from the CIBMTR registry by Frederick L Locke, Grant Schofield, Marcelo Pasquini, Matthew J Frigault, Cameron J Turtle, Stephen Lim, Brian Hill, Samantha Jaglowski, Caron A Jacobson, Gunjan Shah, Daniel J Landsburg, Michael Heim, Stephen Ronan Foley, Ron Ram, Peter A Riedell, Leslie L Popplewell, Ranjan Tiwari, Marta Majdan, Aisha Masood

Get full text

Impact of vein-to-vein time in patients with R/R LBCL treated with axicabtagene ciloleucel by Frederick L. Locke, Tanya Siddiqi, Caron A. Jacobson, Sarah Nikiforow, Sairah Ahmed, David B. Miklos, Yi Lin, Matthew A. Lunning, Brian T. Hill, Armin Ghobadi, Zhen-Huan Hu, Michael T. Hemmer, Michael J. Zoratti, Suresh Vunnum, Jonathan Tsang, Clare Spooner, Harry Smith, Christine Fu, Anik Patel, Harry Miao, Shilpa A. Shahani, Debbie L. Mirjah, Hairong Xu, Marcelo C. Pasquini

Get full text

Longitudinal analysis of gut microbiome and metabolome correlates of response and toxicity with idecabtagene vicleucel by Satabdi Saha, Lubna Rehman, Abdur Rehman, Faezeh Darbaniyan, Donna M. Weber, Melody Becnel, Mahmoud Gaballa, Sheeba K. Thomas, Hans C. Lee, Chia-Chi Chang, Reetakshi Arora, Meghan Menges, Salvatore Corallo, Marco L. Davila, Frederick L. Locke, Mark R. Tanner, Sattva S. Neelapu, Elizabeth J. Shpall, Christopher R. Flowers, Robert Z. Orlowski, Robert R. Jenq, Michael D. Jain, Christine Peterson, Doris K. Hansen, Neeraj Y. Saini, Krina K. Patel

Get full text

Comparison of axicabtagene ciloleucel and tisagenlecleucel patient CAR-T cell products by single-cell RNA sequencing by Xuefeng Wang, Paulo C Rodriguez, Frederick L Locke, Xiaoqing Yu, Marco L Davila, Salvatore Corallo, Bijal Shah, Kayla Reid, Michael D Jain, Sean J Yoder, Chaomei Zhang, Reginald Atkins, Meghan A Menges, Ling Cen, Jerald D Noble, Turab J Mohammad, Christina A Bachmeier, Samira Naderinezhad, Lanmin Zhang, Julieta Abraham Miranda, Julio C Chavez, Rebecca S Hesterberg, Luis Cuadrado Delgado, Constanza Savid-Frontera, John L Cleveland

Get full text

Is CAR T a drug or a therapeutic pathway? Intention to treat versus per protocol analysis of real world studies of CAR-T cell therapy in relapsed refractory diffuse large B cell ly... by Rossana Di Staso, Beatrice Casadei, Frederick L. Locke, Michael Jain, Timothy J. Voorhees, Adam S. Kittai, Mariana Bastos-Oreiro, Antonio Gutiérrez, Alejandro Martin Garcia-Sancho, Maria Jose Terol, Monica Mead, Michael J. Maranzano, Gloria Iacoboni, Pere Barba, Mi Kwon, Rebeca Bailen, Juan Luis Reguera-Ortega, Agrima Mian, Brian Hill, Emmanuel Bachy, Franck Morschhauser, Roch Houot, Catherine Thieblemont, Steven Le Gouill, Riccardo Masetti, Davide Gori, Alessandro Broccoli, Pier Luigi Zinzani, Lisa Argnani

Get full text

Cytopenias and infections following ciltacabtagene autoleucel in heavily-pretreated relapsed or refractory multiple myeloma by Danai Dima, Jennifer M. Logue, Syed Hamza Bin Waqar, Lauren C. Peres, Christelle M. Colin-Leitzinger, Gabriel De Avila, Eric C. Smith, Lawrence Skelson, Kristy L. Matte, Brandon Blue, Vanna N. Hovanky, Mahmoud Gaballa, Oren Pasvolsky, Laura B. Oswald, Gliceida Galarza M. Fortuna, Charlotte B. Wagner, Shaun DeJarnette, Christen Dillard, Fabiana Perna, Lekha Mikkilineni, Hitomi Hosoya, Ciara L. Freeman, Kenneth H. Shain, Rachid C. Baz, Ariel Grajales-Cruz, Omar Castaneda Puglianini, Melissa Alsina, Frederick L. Locke, Leyla O. Shune, Douglas W. Sborov, Krina K. Patel, Surbhi Sidana, Doris K. Hansen

Get full text